PrairieView Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$34K Hold
378
﹤0.01% 211
2025
Q1
$35K Sell
378
-394
-51% -$35.3K ﹤0.01% 207
2024
Q4
$70K Hold
772
0.01% 175
2024
Q3
$80K Hold
772
0.01% 164
2024
Q2
$74K Sell
772
-20
-3% -$1.84K 0.01% 177
2024
Q1
$72K Hold
792
0.01% 160
2023
Q4
$63K Hold
792
0.01% 165
2023
Q3
$56K Hold
792
0.01% 168
2023
Q2
$61K Sell
792
-11
-1% -$851 0.01% 183
2023
Q1
$60K Buy
803
+11
+1% +$818 0.01% 173
2022
Q4
$62K Hold
792
0.01% 173
2022
Q3
$56K Hold
792
0.01% 166
2022
Q2
$63K Hold
792
0.01% 169
2022
Q1
$60K Hold
792
0.01% 181
2021
Q4
$68K Hold
792
0.01% 184
2021
Q3
$60K Hold
792
0.01% 152
2021
Q2
$64K Hold
792
0.01% 150
2021
Q1
$62K Hold
792
0.01% 149
2020
Q4
$68K Hold
792
0.01% 137
2020
Q3
$61K Hold
792
0.01% 130
2020
Q2
$58K Hold
792
0.01% 131
2020
Q1
$53K Buy
+792
New +$55.9K 0.01% 130

Other funds holding CL

PrairieView Partners's CL Position: Q2 2025 in Review

PrairieView Partners held its Colgate-Palmolive (CL) position steady in Q2 2025 at 378 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #211.

PrairieView Partners first reported a position in CL in Q1 2020 and has held it in 22 quarters since. The position peaked at $80K in Q3 2024. 1,913 funds tracked by Wall St. Rank hold CL as of Q2 2025.

  • PrairieView Partners held 378 shares of Colgate-Palmolive worth $34K as of Q2 2025.
  • PrairieView Partners left its Colgate-Palmolive share count unchanged in Q2 2025.
  • Colgate-Palmolive made up ﹤0.01% of PrairieView Partners's portfolio in Q2 2025, its #211 holding.
  • PrairieView Partners first reported a position in Colgate-Palmolive in Q1 2020 and has held it in 22 quarters since.
  • PrairieView Partners's Colgate-Palmolive position peaked at $80K in Q3 2024.
  • 1,913 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2025.

Based on PrairieView Partners's 13F filing for Q2 2025, filed 25 Jul 2025.